News
Chinese teams publish phase 1 gene therapy results in adolescents with haemophilia B
AI-assisted summary Written by WellCareChina with AI assistance and checked against the original article.
The Chinese Academy of Medical Sciences said on 24 September 2026 that teams from its Institute of Hematology, Tongji Hospital and a biotechnology company published a phase 1 trial of an AAV gene therapy in adolescents with haemophilia B in Nature Medicine. The academy’s account describes the results as preliminary evidence for this age group. This item summarises that announcement; it does not assess any treatment.
Read the original article Opens the original source in a new tab.
Copyright and re-use
The original article is the authoritative text. This page carries our own summary and a link back; no part of the original is reproduced here.
Source tier B — headline, our own summary and a link back only; no full-text copy.